(Q54373860)

28 May 2018

title

Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir. (English)

1 reference

28 May 2018

1 reference

1 reference

Bart Takkenberg

1

1 reference

28 May 2018

Valeska Terpstra

2

1 reference

28 May 2018

Hans Zaaijer

3

1 reference

28 May 2018

Christine Weegink

4

1 reference

28 May 2018

Marcel Dijkgraaf

5

1 reference

28 May 2018

Peter Jansen

6

1 reference

28 May 2018

Marcel Beld

7

1 reference

28 May 2018

Hendrik Reesink

8

1 reference

28 May 2018

publication date

1 October 2011

1 reference

28 May 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

28 May 2018

volume

26

1 reference

28 May 2018

issue

10

1 reference

28 May 2018

page(s)

1527-1535

1 reference

28 May 2018

Hepatitis B virus biology

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Control of cccDNA function in hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06766.X

10.1111/J.1440-1746.2011.06766.X

21 January 2018

Identifiers

DOI

1 reference

28 May 2018

1 reference

28 May 2018